## Core Concept
Hemoglobin Poland, also known as Hb Poland, is a rare hemoglobin variant. It results from a deletion mutation in the HBA2 gene, leading to a frameshift and the synthesis of an abnormal peptide chain. This condition affects the structure and function of hemoglobin.

## Why the Correct Answer is Right
The correct answer, , refers to a deletion of 4 nucleotides (nt) in the HBA2 gene. This specific deletion causes a frameshift mutation, resulting in the synthesis of a truncated and abnormal peptide chain. This abnormality leads to the production of Hemoglobin Poland. The deletion of 4 nucleotides is characteristic of this particular hemoglobin variant.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is incorrect because a 3-nucleotide deletion would not cause a frameshift mutation in the same way a 4-nucleotide deletion does, leading to a different type of abnormal peptide chain or no abnormality at all if it results in an in-frame deletion.
* **Option B:** - This option refers to a different type of mutation or variation and does not accurately describe the genetic basis of Hemoglobin Poland.
* **Option D:** - This option is incorrect as it does not specify the correct nature of the mutation associated with Hemoglobin Poland.

## Clinical Pearl / High-Yield Fact
A key point to remember is that Hemoglobin Poland is associated with a deletion mutation in the HBA2 gene. Understanding the genetic basis of hemoglobinopathies, such as the specific mutation leading to Hemoglobin Poland, is crucial for diagnosis and management.

## Correct Answer Line
**Correct Answer: C.**